Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INMUNE-BIO-INC-54264494/news/INmune-Bio-Inc-Announces-First-Patient-Dosed-in-Phase-1-2-Study-of-INKmune-in-Patients-with-Metast-45662231/?utm_source=whatsapp&utm_medium=social&utm_campaign=share